Distribution of PINK1 and LRRK2 in rat and mouse brain

被引:148
作者
Taymans, Jean-Marc [1 ]
Van den Haute, Chris [1 ]
Baekelandt, Veerle [1 ]
机构
[1] Katholieke Univ Leuven, Div Mol Med, Lab Neurobiol & Gene Therapy, B-3000 Louvain, Belgium
关键词
in situ hybridization histochemistry; leucine-rich repeat kinase 2; Parkinson's disease; PTEN induced kinase 1; quantitative RT-PCR; western blot; EARLY-ONSET PARKINSONISM; MESSENGER-RNA; DISEASE; MUTATIONS; EXPRESSION; LOCALIZATION; CLONING; AREAS; DJ-1; GENE;
D O I
10.1111/j.1471-4159.2006.03919.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in two kinases, PTEN induced kinase 1 (PINK1) and leucine-rich repeat kinase 2 (LRRK2), have been shown to segregate with familial forms of Parkinson's disease. Although these two genes are expected to be involved in molecular mechanisms relevant to Parkinson's disease, their precise anatomical localization in mammalian brain is unknown. We have mapped the expression of PINK1 and LRRK2 mRNA in the rat and mouse brain via in situ hybridization histochemistry using riboprobes. We found that both genes are broadly expressed throughout the brain with similar neuroanatomical distribution in mouse compared to rat. PINK1 mRNA abundance was rather uniform throughout the different brain regions with expression in cortex, striatum, thalamus, brainstem and cerebellum. LRRK2, on the other hand, showed strong regional differences in expression levels with highest levels seen in the striatum, cortex and hippocampus. Weak LRRK2 expression was seen in the hypothalamus, olfactory bulb and substantia nigra. We confirmed these distributions for both genes using quantitative RT-PCR and for LRRK2 by western immunoblot. As their broad expression patterns contrast with localized neuropathology in Parkinson's disease, the pathogenicity of clinical mutant forms of PINK1 and LRRK2 may be mediated by nigrostriatal-specific mechanisms.
引用
收藏
页码:951 / 961
页数:11
相关论文
共 34 条
[1]   PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation [J].
Adams, JR ;
van Netten, H ;
Schulzer, M ;
Mak, E ;
Mckenzie, J ;
Strongosky, A ;
Sossi, V ;
Ruth, TJ ;
Lee, CS ;
Farrer, M ;
Gasser, T ;
Uitti, RJ ;
Calne, DB ;
Wszolek, ZK ;
Stoessl, AJ .
BRAIN, 2005, 128 :2777-2785
[2]   Expression of DJ-1 in the adult mouse CNS [J].
Badera, V ;
Zhu, XR ;
Lübbert, H ;
Stichel, CC .
BRAIN RESEARCH, 2005, 1041 (01) :102-111
[3]   Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain [J].
Baekelandt, V ;
Eggermont, K ;
Michiels, M ;
Nuttin, B ;
Debyser, Z .
GENE THERAPY, 2003, 10 (23) :1933-1940
[4]   Roc, a Ras/GTPase domain in complex proteins [J].
Bosgraaf, L ;
Van Haastert, PJM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3) :5-10
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Cloning and distribution of the rat parkin mRNA [J].
D'Agata, V ;
Zhao, WQ ;
Cavallaro, S .
MOLECULAR BRAIN RESEARCH, 2000, 75 (02) :345-349
[7]   LRRK2 expression linked to dopamine-innervated areas [J].
Galter, D ;
Westerlund, M ;
Carmine, A ;
Lindqvist, E ;
Sydow, O ;
Olson, L .
ANNALS OF NEUROLOGY, 2006, 59 (04) :714-719
[8]   Genetics of Parkinson's disease [J].
Gasser, T .
CURRENT OPINION IN NEUROLOGY, 2005, 18 (04) :363-369
[9]  
Gerfen CR., 2004, RAT NERVOUS SYSTEM, V3, P455, DOI [10.1016/B978-012547638-6/50019-5, DOI 10.1016/B978-012547638-6/50019-5]
[10]   Biochemical and pathological characterization of Lrrk2 [J].
Giasson, BI ;
Covy, JP ;
Bonini, NM ;
Hurtig, HI ;
Farrer, MJ ;
Trojanowski, JQ ;
Van Deerlin, VM .
ANNALS OF NEUROLOGY, 2006, 59 (02) :315-322